|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 2771031 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12844433.8 |
| Date of filing the European patent application | 2012-10-26 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation | 2018-08-27 |
| (86) | Number | PCT/US2012/062290 |
| Date | 2012-10-26 |
| (87) | Number | WO 2013/063516 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161553131 P | 2011-10-28 | US | |
| 201261711208 P | 2012-10-08 | US |
| (72) |
SALDANHA, Jose, GB
NIJJAR, Tarlochan S., US
|
| (73) |
Prothena Biosciences Limited,
Adelphi Plaza Upper George`s Street D n Laoghaire, Co. Dublin, A96 T927,
IE
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti antikūnai, kurie atpažįsta alfa sinukleiną |
| HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN |
| Payment date | Validity (years) | Amount | |
| 2024-09-20 | 13 | 289.00 EUR |
| 2025-10-26 |